StockData
OptimizeRx Corp logo

OptimizeRx Corp (OPRX) stock

OPRXNasdaqServices-Business Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/3030% below fair value
$6.94+0.30 (+4.52%)

Close on Nov 17, 2026Market cap $130.72MP/E 28.9Yield –

OptimizeRx pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

OptimizeRx's pe ratio was 37.3× on Nov 11, 2026, against 928.6× a year earlier. Over the last 2 years it ranged from 14.4× to 928.6×, with a median of 325.0×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202637.3×−604.6
2022Jan 31, 2022641.9×−245.4
2021Dec 31, 2021887.3×+678.5
2020Feb 28, 2020208.8×−48.0
2019Dec 31, 2019256.8×−365.1
2016Jan 29, 2016621.9×−80.6
2015Dec 31, 2015702.5×–

More OptimizeRx figures

See a number that looks wrong?